Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Tumori|May 1, 1975
[Description of a case of acute neurological toxicity after DTIC-adriamycin-vincristine therapy (author's transl)]R Rosso, F Brema, G PorcileTumori|February 28, 1979
In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storageF Patrone, F Dallegri, F Brema, et al.Experimental Hematology|March 1, 1979
Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugationF Patrone, F Dallegri, F Brema, et al.Tumori|January 1, 1976
[Antitumoral activity of calusterone in advanced mammary carcinoma (author's transl)]R Rosso, F Brema, G F Porcile, et al.Tumori|March 1, 1995
Combination of epirubicin and lonidamine for treatment of advanced breast cancerL Moraglio, F Brema, G Pastorino, et al.Tumori|October 31, 1984
Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumorsM T Nobile, R Rosso, F Brema, et al.American Journal of Clinical Oncology|June 1, 1997
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide, and cisplatin (CEP)A Ballestrero, F Ferrando, P Stura, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1990
Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancerF Boccardo, L Canobbio, M Resasco, et al.American Journal of Clinical Oncology|August 1, 1985
Phase II study of teniposide (VM-26) in multiple myelomaU Tirelli, A Carbone, V Zagonei, et al.Tumori|March 1, 1981
Hematologic parameters during treatment with high-dose medroxyprogesterone acetateF Brema, M A Queirolo, L Canobbio, et al.Pageof 3